Amgen Inc (AMGN)

249.62 -0.33  -0.13% NASDAQ Apr 14, 20:00 USD
View Full Chart
Price Chart
View All AMGN News

News

View All Events

Events

Date Type Description
04/30/2020 00:00 Earnings Results Q1 2020 Earnings Results
04/30/2020 14:00 PDT Earnings Calls Q1 2020 Earnings Call
05/15/2020 None Dividends 1.60 Normal, declared March 04, 2020 and paid June 08, 2020
05/19/2020 11:00 PDT Agm 2019 Annual General Meeting
07/28/2020 14:00 PDT Earnings Calls Q2 2020 Earnings Call
07/28/2020 00:00 Earnings Results Q2 2020 Earnings Results
08/14/2020 None Dividends 1.60 Normal, declared July 23, 2020 and paid September 08, 2020
10/28/2020 00:00 Earnings Results Q3 2020 Earnings Results
10/28/2020 14:00 PDT Earnings Calls Q3 2020 Earnings Call
11/13/2020 None Dividends 1.60 Normal, declared October 21, 2020 and paid December 08, 2020
View All Performance Charts

Total Returns Comparison

Ratings & Reports

Advertisement
Edit

Profile

  • Description: Amgen is a leader in biotechnology-based human therapeutics, with historical expertise in renal disease and cancer supportive-care products. Flagship drugs include red blood cell boosters Epogen and Aranesp, immune system boosters Neupogen and Neulasta, and Enbrel and Otezla for inflammatory diseases. Amgen introduced its first cancer therapeutic, Vectibix, in 2006 and markets bone-strengthening drug Prolia/Xgeva (approved 2010) and Evenity (approved 2019). The acquisition of Onyx bolstered the firm's therapeutic oncology portfolio with Nexavar and Kyprolis. Recent launches include Repatha (cholesterol-lowering) and Aimovig (migraine). Amgen's own biosimilar portfolio includes key products Mvasi (biosimilar Avastin), Kanjinti (biosimilar Herceptin), and Amgevita (biosimilar Humira).
  • URL: https://www.amgen.com
  • Investor Relations URL: http://investors.amgen.com/phoenix.zhtml?c=61656&p=irol-IRHome
  • HQ State/Province: California
  • Sector: Healthcare
  • Industry: Drug Manufacturers - General
  • Equity Style: Large Cap/Value
  • Next Earnings Release: Apr. 30, 2021
  • Last Earnings Release: Feb. 02, 2021
  • Next Ex-Dividend Date: May. 14, 2021
  • Last Ex-Dividend Date: Feb. 11, 2021

Top Fund Holders

Symbol Name Weighting
IBB iShares Nasdaq Biotechnology ETF 9.34%
DIA SPDR® Dow Jones Industrial Avrg ETF Tr 4.88%
SCHD Schwab US Dividend Equity ETF™ 4.08%
VPMAX Vanguard PRIMECAP Adm 3.26%
XLV Health Care Select Sector SPDR® ETF 3.25%
VHT Vanguard Health Care ETF 2.46%
AMRFX American Funds American Mutual F2 2.16%
FBCIX American Funds Capital Income Bldr 529F2 1.67%
RIBEX American Funds Invmt Co of Amer R2E 1.23%
QQQ Invesco QQQ Trust 1.10%
CWGIX American Funds Capital World Gr&Inc A 1.07%

Comparables

Edit
Advertisement

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}

Please note that this feature is only available as an add-on to YCharts subscriptions.


Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial {{root.upsell.info.call_to_action}} No credit card required.

Already a subscriber? Sign in.